Canada Pharmacy Backs Zoledronic Acid to Stop Skeletal-Related Events in Cancer Patients

Onset of skeletal-related events (SREs) in patients suffering from advanced renal cell carcinoma (RCC) is not uncommon, but our Canadian pharmacy backs Zoledronic acid in preventing SREs and skeletal disease progression in patients suffering from bone metastases. Earlier results have indicated a high percentage of SREs developed when patients suffering from renal cell carcinoma had […]

Continue reading